Construction and Characterization of Novel, Completely Human Serine Protease Therapeutics Targeting Her2/Neu

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-13-0002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

HER2/neu Antisense Therapeutics in Human Breast Cancer

2002English

Targeting the Function of the HER2 Oncogene in Human Cancer Therapeutics

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Spectral Fluorescence Molecular Imaging of Lung Metastases Targeting HER2/neu

Clinical Cancer Research
Cancer ResearchOncology
2007English

Kempopeptin C, a Novel Marine-Derived Serine Protease Inhibitor Targeting Invasive Breast Cancer

Marine Drugs
Drug Discovery
2017English

Activating Mutations in HER2 : Neu Opportunities and Neu Challenges

Cancer Discovery
Oncology
2013English

HER2 (EGFR2; ErbB2; Neu)

Science-Business eXchange
2013English

Targeting Her2/Neu in Uterine Serous Carcinoma: A Paradigm Shift in Management

Oncotarget
Oncology
2018English

Construction and Properties of an Intracellular Serine Protease Mutant of Bacillus Subtilis.

Journal of Bacteriology
MicrobiologyMolecular Biology
1987English

HER2 (ERBB2; Neu); Transferrin Receptor

Science-Business eXchange
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy